CD163 and osteosarcoma: In our series no difference in survival according with presence of TAMs, characterized by both CD163 and CD68 expression, was observed (CD163+ 81% vs CD163- 56%, p = 0.17), while in other osteosarcoma series a prognostic role of TAMs was suggested [13, 14].